A new clinical trial will test whether an experimental vaccine can help patients' immune systems to stop the spread of deadly glioblastoma brain cancer.
Glioblastmoa brain cancer patients who received an experimental vaccines in combination with chemotherapy showed improved suitability and tolerated the treatment well, a new study reports.
